Femasys Inc.
Market Cap
$17.08M
P/E Ratio
-0.84
EPS
$-0.69
Dividend Yield
0.00%
52-Week Range
$0.31 — $1.76
Volume
519.54K
Avg Volume
895.60K
Beta
-2.53
P/E (TTM)
-0.84
Forward P/E
—
PEG Ratio
-0.05
P/S (TTM)
8.12
P/B (TTM)
3.60
P/FCF
—
EV/EBITDA
—
EV/Sales
—
ROE (TTM)
-7.64%
ROA (TTM)
-1.22%
ROIC
—
Gross Margin
0.42%
Operating Margin
-8.58%
Net Margin
—
Debt/Equity
1.85
Current Ratio
1.16
EPS Growth (YoY)
—
Revenue Growth (YoY)
—
EPS Growth (3Y)
-0.13%
EPS Growth (5Y)
-0.02%
Sales Growth (3Y)
+0.14%
Sales Growth (5Y)
+0.14%
EPS Est (This Year)
$-0.41
EPS Est (Next Year)
$-0.28
Dividend Yield
—
Annual Dividend
—
Payout Ratio
—
Frequency
—
Ex-Dividend Date
—
Cash/Share
$0.16
Institutional %
—
Inst. Net Change
—
Insider Net Shares (90d)
—
Outstanding Shares
29.45M
Float
22.86M
Free Float %
77.63%
Sector
Healthcare
Industry
Medical - Instruments & Supplies
Country
US
Exchange
NASDAQ
IPO Date
2021-06-18
Employees
69
CEO
Kathy Lee-Sepsick
Index Membership
—
Website
https://www.femasys.com
Femasys Inc. (FEMY) is a healthcare company in the medical - instruments & supplies industry listed on the NASDAQ. With a market capitalization of $17.08M, a P/E ratio of -0.84, FEMY is tracked by stockscreenr alongside 25,000+ other tickers. Use the free stock screener to compare FEMY against other stocks using dozens of fundamental and technical filters.
Femasys Inc. (FEMY) has a trailing twelve-month (TTM) P/E ratio of -0.84. This is below the market average, which may suggest the stock is undervalued or has lower growth expectations. The P/E ratio measures how much investors are willing to pay per dollar of earnings.
No, Femasys Inc. (FEMY) does not currently pay a regular dividend. The company may be reinvesting profits into growth, research, or debt reduction instead of returning cash to shareholders through dividends.
Femasys Inc. (FEMY) has a market capitalization of $17.08 million, classifying it as a micro-cap company. Market cap is calculated by multiplying the current share price by the total number of outstanding shares.